Abstract: With the increasing demand for power levels in medium and low voltage applications such as ships and warships, wind power generation systems. The multiphase generators are receiving the ...

Roche said it has removed its thrombolytic drug tenecteplase from phase 3 for for acute ischaemic stroke, along with several earlier-stage projects. The fibrin-specific plasminogen activator – which ...